News > India’s first mRNA vaccine receives approval for clinical trials
India’s first mRNA vaccine receives approval for clinical trials
The Siasat | 10/12/2020 10:01 AM | Click to read full article
The Central Drugs Standard Control Organisation on Wednesday permitted Pune-based Gennova Biopharmaceuticals to conduct Phase 1/2 clinical trials, along with animal toxicity data, for its mRNA Covid-19 vaccine candidate. It is India’s first messenger RNA (mRNA), Covid vaccine candidate. Globally, US-based pharma giant Pfizer Inc has developed its mRNA vaccine.
The Union Health Ministry had on Tuesday said that as many as eight vaccine candidates for Covid-19 are under different stages of clinical trials.
